Folate Malabsorption, Hereditary
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Malignant neoplasm of prostate
|
0.020 |
Biomarker
|
disease |
BEFREE |
Effect of small molecules modulating androgen receptor (SARMs) in human prostate cancer models.
|
23667504 |
2013 |
Prostate carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Effect of small molecules modulating androgen receptor (SARMs) in human prostate cancer models.
|
23667504 |
2013 |
Infections, Bunyavirus
|
0.010 |
Biomarker
|
disease |
BEFREE |
Activation of the innate signaling molecule MAVS by bunyavirus infection upregulates the adaptor protein SARM1, leading to neuronal death.
|
23499490 |
2013 |
Respiratory Syncytial Virus Infections
|
0.310 |
Biomarker
|
group |
CTD_human |
We hypothesize that resveratrol inhibits the TRIF-dependent pathway through upregulation of SARM post-RSV infection.
|
24478430 |
2014 |
Respiratory Syncytial Virus Infections
|
0.310 |
AlteredExpression
|
group |
BEFREE |
We hypothesize that resveratrol inhibits the TRIF-dependent pathway through upregulation of SARM post-RSV infection.
|
24478430 |
2014 |
Osteoprotegerin test
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Meta-analysis of genome-wide association studies identifies two loci associated with circulating osteoprotegerin levels.
|
25080503 |
2014 |
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
|
0.010 |
Biomarker
|
disease |
BEFREE |
SARM short interfering RNA was administered to RSV-infected and resveratrol-treated mice.
|
24478430 |
2014 |
Amyotrophic Lateral Sclerosis
|
0.120 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis.
|
27455348 |
2016 |
Malignant neoplasm of prostate
|
0.020 |
Biomarker
|
disease |
BEFREE |
Long term treatment with therapies aimed at blocking the estrogen- (ER) or androgen receptor (AR) action often leads to the development of resistance to selective modulators of the estrogen receptor (SERMs) in ERα-positive breast cancer, or of the androgen receptor (SARMs) in AR-positive prostate cancer.
|
26803986 |
2016 |
Prostate carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Long term treatment with therapies aimed at blocking the estrogen- (ER) or androgen receptor (AR) action often leads to the development of resistance to selective modulators of the estrogen receptor (SERMs) in ERα-positive breast cancer, or of the androgen receptor (SARMs) in AR-positive prostate cancer.
|
26803986 |
2016 |
Low density lipoprotein cholesterol measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Exome-wide association study of plasma lipids in >300,000 individuals.
|
29083408 |
2017 |
AMYOTROPHIC LATERAL SCLEROSIS 6 (disorder)
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Cross-ethnic meta-analysis identifies association of the GPX3-TNIP1 locus with amyotrophic lateral sclerosis.
|
28931804 |
2017 |
AMYOTROPHIC LATERAL SCLEROSIS 1
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Cross-ethnic meta-analysis identifies association of the GPX3-TNIP1 locus with amyotrophic lateral sclerosis.
|
28931804 |
2017 |
Amyotrophic Lateral Sclerosis, Sporadic
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Cross-ethnic meta-analysis identifies association of the GPX3-TNIP1 locus with amyotrophic lateral sclerosis.
|
28931804 |
2017 |
Interleukin 5 Measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Connecting genetic risk to disease end points through the human blood plasma proteome.
|
28240269 |
2017 |
AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL RECESSIVE
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Cross-ethnic meta-analysis identifies association of the GPX3-TNIP1 locus with amyotrophic lateral sclerosis.
|
28931804 |
2017 |
Peripheral Neuropathy
|
0.040 |
Biomarker
|
group |
BEFREE |
Deletion of Sarm1 gene is neuroprotective in two models of peripheral neuropathy.
|
28485482 |
2017 |
Neuropathy
|
0.040 |
Biomarker
|
group |
BEFREE |
In this study, we show that mice lacking the Sarm1 gene are resistant to distal axonal degeneration in a model of chemotherapy induced peripheral neuropathy caused by paclitaxel and a model of high fat diet induced putative metabolic neuropathy.
|
28485482 |
2017 |
Peripheral Nervous System Diseases
|
0.040 |
Biomarker
|
group |
BEFREE |
This study extends the role of Sarm1 to axon degeneration seen in peripheral neuropathies and identifies it as a likely target for therapeutic development.
|
28485482 |
2017 |
Peripheral neuropathy due to and following chemotherapy
|
0.020 |
Biomarker
|
disease |
BEFREE |
In this study, we show that mice lacking the Sarm1 gene are resistant to distal axonal degeneration in a model of chemotherapy induced peripheral neuropathy caused by paclitaxel and a model of high fat diet induced putative metabolic neuropathy.
|
28485482 |
2017 |
Chronic Obstructive Airway Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
COPD = chronic obstructive pulmonary disease DHEA = dehydroepiandrosterone IGF-1 = insulin-like growth factor 1 GH = growth hormone mTOR = mammalian target of rapamycin SARM = selective androgen receptor molecule.
|
28704095 |
2017 |
Amyotrophic Lateral Sclerosis
|
0.120 |
Biomarker
|
disease |
BEFREE |
Our data suggest the molecular pathways driving axon loss in ALS may be Sarm1-independent or involve genetic pathways that act in a redundant fashion with Sarm1.
|
30010873 |
2018 |
Low density lipoprotein cholesterol measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
A large electronic-health-record-based genome-wide study of serum lipids.
|
29507422 |
2018 |
Low density lipoprotein cholesterol measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program.
|
30275531 |
2018 |